The Nigerian Exchange Limited (NGX) has seen an unprecedented wave of corporate exits in 2024, with 15 companies either voluntarily or forcibly delisted due to strategic restructuring, operational challenges, or non-compliance with listing requirements. Among the prominent departures is GlaxoSmithKline Consumer Nigeria Plc, a move that underscores the shifting dynamics within Nigeria’s corporate landscape. GSK...

The post Delisting: Strategic Overhaul Forces 15 Firms Out Of Exchange appeared first on New Telegraph.